# Irinotecan in Treating Patients With Metastatic Colorectal Cancer

> **NCT00003544** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** irinotecan hydrochloride
- **PROCEDURE:** surgical procedure

## Key facts

- **NCT ID:** NCT00003544
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** 2001-03
- **Final completion:** 2001-03
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003544, "Irinotecan in Treating Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00003544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*